Clinical Trial Update: Capadenoson in Angina Pectoris [Phase 2]

View source ↗

Summary

A Phase 2 trial of Capadenoson for chronic stable angina has been withdrawn by sponsor Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina

Drugs mentioned

• Capadenoson (Capadenoson)

Snippet

Sponsor: Bayer | Conditions: Chronic Stable Angina | Phase 2 | Status: WITHDRAWN